CALR and neoplasm: This form activates antitumor immune responses by promoting the exposure and release of damage‐associated molecular patterns (DAMPs), such as calreticulin, ATP, and HMGB1, which stimulate dendritic cell maturation and tumor‐specific T lymphocyte responses.16, 20